![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SLC6A14 |
Gene summary for SLC6A14 |
![]() |
Gene information | Species | Human | Gene symbol | SLC6A14 | Gene ID | 11254 |
Gene name | solute carrier family 6 member 14 | |
Gene Alias | BMIQ11 | |
Cytomap | Xq23 | |
Gene Type | protein-coding | GO ID | GO:0003333 | UniProtAcc | B2R8J1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11254 | SLC6A14 | P8T-E | Human | Esophagus | ESCC | 1.42e-32 | 1.43e+00 | 0.0889 |
11254 | SLC6A14 | P20T-E | Human | Esophagus | ESCC | 7.60e-05 | -4.86e-02 | 0.1124 |
11254 | SLC6A14 | P36T-E | Human | Esophagus | ESCC | 1.14e-15 | 1.37e+00 | 0.1187 |
11254 | SLC6A14 | P47T-E | Human | Esophagus | ESCC | 1.00e-05 | -4.04e-02 | 0.1067 |
11254 | SLC6A14 | P57T-E | Human | Esophagus | ESCC | 1.94e-04 | 2.94e-01 | 0.0926 |
11254 | SLC6A14 | P61T-E | Human | Esophagus | ESCC | 4.28e-05 | 3.42e-01 | 0.099 |
11254 | SLC6A14 | P75T-E | Human | Esophagus | ESCC | 9.96e-23 | 1.36e+00 | 0.1125 |
11254 | SLC6A14 | P76T-E | Human | Esophagus | ESCC | 1.30e-23 | 8.03e-01 | 0.1207 |
11254 | SLC6A14 | P82T-E | Human | Esophagus | ESCC | 9.85e-06 | 1.44e+00 | 0.1072 |
11254 | SLC6A14 | P84T-E | Human | Esophagus | ESCC | 1.04e-04 | 1.35e-01 | 0.0933 |
11254 | SLC6A14 | C21 | Human | Oral cavity | OSCC | 4.50e-04 | 1.29e+00 | 0.2678 |
11254 | SLC6A14 | SYSMH6 | Human | Oral cavity | OSCC | 5.66e-07 | 3.58e-01 | 0.1275 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000963620 | Esophagus | ESCC | response to toxic substance | 150/8552 | 262/18723 | 1.00e-04 | 7.12e-04 | 150 |
GO:000963618 | Oral cavity | OSCC | response to toxic substance | 137/7305 | 262/18723 | 7.94e-06 | 8.52e-05 | 137 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SLC6A14 | SNV | Missense_Mutation | novel | c.280N>G | p.Cys94Gly | p.C94G | Q9UN76 | protein_coding | deleterious(0) | possibly_damaging(0.491) | TCGA-BR-A4QL-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | xeloda | CR |
SLC6A14 | SNV | Missense_Mutation | c.526N>G | p.Ser176Gly | p.S176G | Q9UN76 | protein_coding | tolerated(0.14) | benign(0.003) | TCGA-CD-8525-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Chemotherapy | epirubicin | CR | |
SLC6A14 | SNV | Missense_Mutation | c.1118N>T | p.Ala373Val | p.A373V | Q9UN76 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-CG-4305-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | cisplatin | CR | |
SLC6A14 | SNV | Missense_Mutation | novel | c.1396N>A | p.Val466Met | p.V466M | Q9UN76 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-MX-A5UJ-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
SLC6A14 | deletion | Frame_Shift_Del | novel | c.126delA | p.Lys42AsnfsTer8 | p.K42Nfs*8 | Q9UN76 | protein_coding | TCGA-BR-4370-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
SLC6A14 | insertion | Frame_Shift_Ins | novel | c.489_490insCAAACTCAAGTAAAATTTACTT | p.Cys164GlnfsTer9 | p.C164Qfs*9 | Q9UN76 | protein_coding | TCGA-EL-A3ZG-01 | Thyroid | thyroid carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
11254 | SLC6A14 | EXTERNAL SIDE OF PLASMA MEMBRANE, TRANSPORTER, DRUGGABLE GENOME | inhibitor | 178101406 |
Page: 1 |